Related Experiment Video

Updated: Sep 6, 2025

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

38.3K

Role of ABCA1 in Cardiovascular Disease

Jing Wang1,2, Qianqian Xiao1,2, Luyun Wang1,2

  • 1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Journal of Personalized Medicine
|June 24, 2022
PubMed

Insights

ATP-binding cassette transporter A1 (ABCA1) is crucial for cholesterol homeostasis and cardiovascular health. Dysregulation of ABCA1, through genetic mutations or altered expression, increases the risk of cardiovascular diseases like atherosclerosis and heart attack.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Science

Background:

  • Cholesterol homeostasis is vital for preventing cardiovascular disease.
  • ATP-binding cassette transporter A1 (ABCA1) is a key protein regulating cholesterol homeostasis.
  • ABCA1 facilitates cholesterol efflux and nascent HDL biogenesis, impacting reverse cholesterol transport.

Purpose of the Study:

  • To review the regulatory mechanisms of ABCA1, including transcription, mutations, and post-translational modifications.
  • To elucidate the role of ABCA1 in various cardiovascular conditions.
  • To highlight the significance of ABCA1 in maintaining lipid homeostasis and preventing inflammation.

Main Methods:

  • Literature review and synthesis of existing research on ABCA1.
  • Analysis of studies focusing on ABCA1 gene regulation, mutations, and post-translational modifications.
  • Examination of ABCA1's involvement in dyslipidemia, atherosclerosis, and other cardiovascular diseases.

Main Results:

  • ABCA1's function is significantly influenced by post-transcriptional modifications affecting its localization and activity.
  • Loss-of-function ABCA1 mutations are linked to reduced ABCA1 expression and elevated cardiovascular disease risk.
  • ABCA1 plays a dual role in cardiovascular health by maintaining lipid balance and suppressing inflammation.

Conclusions:

  • ABCA1 is a critical determinant of cardiovascular health, influencing lipid metabolism and inflammatory responses.
  • Understanding ABCA1 regulation is essential for developing therapeutic strategies against cardiovascular diseases.
  • Aberrant ABCA1 function, due to genetic or post-translational changes, contributes to the pathogenesis of major cardiovascular conditions.

Keywords:
ATP binding cassette transporter 1 (ABCA1)cardiovascular diseasecholesterolhigh density lipoprotein cholesterol (HDL-C)inflammationpolymorphismpost-translational modification (PTM)transcription regulation

More Related Videos

Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.0K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
73
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.9K